Morgan Armstrong, PA
Medical · West Columbia, SCNPI 1790148823
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 345 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 29 manufacturers reported payments, led by AbbVie at 33.3% of the total.
Across 345 payments — averaging $16.27 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- Novo Nordisk$795
- Lilly USA, LLC$633
- AstraZeneca$406
- Pfizer$323
- Amgen$290
- plus $1K from 23 others
What the payments were for
- Food & beverage$5,615100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 125 | $1,872 |
| Novo Nordisk | 46 | $795 |
| Lilly USA, LLC | 49 | $633 |
| AstraZeneca | 17 | $406 |
| Pfizer | 20 | $323 |
| Amgen | 16 | $290 |
| Novartis | 8 | $140 |
| Abbott | 8 | $139 |
| Dexcom, Inc. | 4 | $132 |
| GSK | 6 | $96 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 5 | $87 |
| Merck | 5 | $84 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $79 |
| Biohaven Pharmaceutical Holding Company Ltd. | 4 | $78 |
| Exact Sciences | 4 | $75 |
| Amarin Pharma, Inc. | 4 | $60 |
| Biohaven Pharmaceuticals, Inc. | 2 | $49 |
| Daiichi Sankyo Inc. | 2 | $47 |
| Corcept Therapeutics | 2 | $38 |
| Phathom Pharmaceuticals, Inc. | 3 | $36 |
| Bayer | 2 | $33 |
| Sunovion Pharmaceuticals Inc. | 1 | $18 |
| Axsome Therapeutics, Inc. | 1 | $17 |
| Esperion Therapeutics, Inc. | 1 | $16 |
| Corium, LLC | 1 | $16 |
| Nestle Healthcare Nutrition Inc. | 1 | $16 |
| Kowa Pharmaceuticals America, Inc. | 1 | $14 |
| Sanofi Pasteur Inc. | 1 | $12 |
| Sanofi-aventis U.S. LLC | 1 | $12 |
How this compares
$5,615 in reported general payments places this provider in the 85th percentile of 384 medical providers in South Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 34 | $48,993 |
| JardianceEmpagliflozin | 53 | $48,800 |
| MounjaroTirzepatide | 37 | $46,228 |
| JanuviaSitagliptin Phosphate | 29 | $27,191 |
| EliquisApixaban | 30 | $22,907 |
| FarxigaDapagliflozin Propanediol | 11 | $11,527 |
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 13 | $5,972 |
| Rosuvastatin Calcium | 49 | $1,732 |
| Atorvastatin Calcium | 150 | $1,698 |
| Sucralfate | 34 | $1,313 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 44 | $1,223 |
| Bupropion XlBupropion Hcl | 44 | $1,183 |
| Omeprazole | 93 | $1,171 |
| CholestyramineCholestyramine (With Sugar) | 14 | $1,139 |
| Metoprolol Succinate | 80 | $930 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $795 | $48,99334 claims |
| Lilly USA, LLCMounjaro | $633 | $46,22837 claims |
| MerckJanuvia | $84 | $27,19129 claims |
| PfizerEliquis | $323 | $22,90730 claims |
| AstraZenecaFarxiga | $406 | $11,52711 claims |
| GSKAnoro Ellipta | $96 | $5,97213 claims |
| AbbVieSynthroid | $1,872 | $69517 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 384 medical providers in South Carolina.
Other medical in West Columbia
- Suzanne SmithWest Columbia$39K
- Anna ScottWest Columbia$16K
- Michelle EvansWest Columbia$9K
- Wilfredo VillarrubiaWest Columbia$5K
- Christopher ThompsonSpartanburg$78K
- Laura BuchGreenville$73K
- Stavros ChrysostomidesColumbia$39K
- Ethan CaseySpartanburg$24K
- Jessica HallColumbia$22K
- Mary MacdonaldCharleston$20K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.